Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 17253639 | 4-(P-TRIFLUOROMETHYLBENZYL)-3-FLUORO-1,2,4-TRIPHENYLAMINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION AND APPLICATIONS THEREOF | December 2020 | December 2021 | Allow | 12 | 1 | 1 | Yes | No |
| 17123004 | METHOD FOR OXIDIZING A 1,1,-BIS-(3,4-DIMETHYLPHENYL)-ALKANE TO 3,3',4,4'-BENZOPHENONE TETRACARBOXYLIC ACID | December 2020 | March 2023 | Allow | 27 | 0 | 1 | No | No |
| 17113248 | MIXTURES OF CANNABINOID COMPOUNDS, AND PRODUCTION AND USE THEREOF | December 2020 | January 2024 | Allow | 37 | 1 | 1 | No | No |
| 17111688 | DIISOCYANATE COMPOSITION, PREPARATION METHOD THEREOF AND OPTICAL MATERIAL USING SAME | December 2020 | March 2024 | Allow | 40 | 2 | 2 | Yes | No |
| 17055129 | PREPARATION OF ZINC LINOLENATE, AND APPLICATION OF ZINC LINOLENATE IN PREPARING ANTI-HELICOBACTER PYLORI DRUG | November 2020 | August 2021 | Allow | 9 | 0 | 1 | Yes | No |
| 17055124 | VINYLSULFONIC ANHYDRIDE, METHOD FOR PRODUCING SAME, AND METHOD FOR PRODUCING VINYLSULFONYL FLUORIDE | November 2020 | March 2023 | Allow | 28 | 1 | 1 | Yes | No |
| 17054435 | OPTIMIZATION OF 2-EH PRODUCT RECOVERY SYSTEM USING PROCESS INTENSIFICATION | November 2020 | September 2021 | Allow | 10 | 1 | 0 | No | No |
| 17090033 | TRISODIUM SACUBITRIL VALSARTAN AND PROCESS FOR ITS PREPARATION | November 2020 | November 2022 | Allow | 25 | 1 | 0 | Yes | No |
| 17050925 | METHOD FOR PREPARING 4,4'-DIHYDROXY-[1,1'-BIPHENYL-3,3'-DICARBOXYLIC ACID] | October 2020 | August 2022 | Allow | 21 | 1 | 0 | No | No |
| 17071013 | PROCESSES FOR PREPARING A 2-(1,2,2-TRIMETHYL-3-CYCLOPENTENYL)-2-OXOETHYL CARBOXYLATE COMPOUND AND HYDROXYMETHYL 1,2,2-TRIMETHYL-3-CYCLOPENTENYL KETONE, AND A HALOMETHYL (1,2,2-TRIMETHYL-3-CYCLOPENTENYL) KETONE COMPOUND | October 2020 | September 2022 | Allow | 23 | 0 | 0 | No | No |
| 17045939 | PROCESS FOR PREPARING 2,6-DIALKYLPHENYLACETIC ACIDS | October 2020 | November 2022 | Allow | 25 | 1 | 1 | Yes | No |
| 17045326 | Method For Preparing Hexahydrofuro-Furanol Derivative, Intermediate Thereof And Preparation Method Thereof | October 2020 | July 2022 | Abandon | 21 | 1 | 1 | No | No |
| 17034030 | PROCESS FOR THE PREPARATION OF FERRIC CITRATE | September 2020 | February 2024 | Abandon | 41 | 2 | 1 | No | No |
| 17032546 | LIGAND AND METHOD OF MANUFACTURING THE SAME, QUANTUM DOT FILM AND METHOD OF MANUFACTURING THE SAME, AND DISPLAY APPARATUS | September 2020 | August 2022 | Allow | 23 | 1 | 1 | Yes | No |
| 17040960 | NOVEL CATIONIC LIPID EXHIBITING IMPROVED INTRACELLULAR DYNAMICS | September 2020 | April 2024 | Allow | 43 | 3 | 1 | No | No |
| 17028689 | NOVEL SUBSTITUTED QUINOLINE-8-CARBONITRILE DERIVATIVES WITH ANDROGEN RECEPTOR DEGRADATION ACTIVITY AND USES THEREOF | September 2020 | August 2022 | Allow | 23 | 0 | 1 | No | No |
| 17040479 | PIPERAZINE AZASPIRO DERIVATIVES | September 2020 | July 2022 | Allow | 22 | 0 | 1 | Yes | No |
| 17040295 | CATALYST COMPOSITIONS AND HYDROFORMYLATION PROCESSES | September 2020 | June 2024 | Allow | 44 | 1 | 1 | Yes | No |
| 16982842 | SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS, ANALOGUES THEREOF, AND METHODS USING SAME | September 2020 | September 2023 | Allow | 36 | 3 | 1 | No | No |
| 17021576 | PROCESS FOR CONTINUOUS ACETIC ACID PRODUCTION | September 2020 | February 2023 | Allow | 29 | 1 | 1 | No | No |
| 16979976 | LONG ALPHA-OMEGA DI-FUNCTIONAL LINEAR ETHERS | September 2020 | December 2022 | Allow | 27 | 1 | 1 | No | No |
| 17016095 | CRYSTALLINE 4-AMINO-2-(2,6-DIOXOPIPERIDINE-3-YL)ISOINDOLINE-1,3-DIONE DIHYDRATE, COMPOSITIONS AND METHODS OF USE THEREOF | September 2020 | July 2022 | Allow | 23 | 1 | 0 | Yes | No |
| 17015988 | PHOSPHONIUM-BASED ZWITTERIONIC MONOMERS AND POLYMERS, AND COMPOSITIONS AND METHODS THEREOF | September 2020 | November 2022 | Allow | 26 | 0 | 1 | Yes | No |
| 16978988 | FRAGRANCE AND FLAVOR MATERIALS DERIVED FROM 1-(4-METHYLCYCLOHEX-1-EN-1-YL)ETHAN-1-ONE | September 2020 | January 2023 | Abandon | 28 | 0 | 1 | No | No |
| 17012286 | PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS | September 2020 | August 2022 | Allow | 23 | 1 | 0 | Yes | No |
| 17000529 | Amphiphilic Diphenyl Ether Compounds Derived from Alpha Olefins or Vinylidene Alpha Olefin Dimers | August 2020 | December 2022 | Abandon | 27 | 1 | 1 | No | No |
| 16970987 | PROCESSES FOR THE MANUFACTURE OF SECONDARY FATTY ALCOHOLS, INTERNAL OLEFINS AND INTERNAL OLEFIN SULFONATES | August 2020 | March 2023 | Allow | 31 | 1 | 1 | No | No |
| 16970113 | METHOD FOR PRODUCING TRICYCLO[5.2.1.02,6]DECANE-2-CARBOXYLATE | August 2020 | September 2021 | Allow | 13 | 1 | 0 | No | No |
| 16969793 | DERIVATIVES OF SOBETIROME | August 2020 | October 2022 | Allow | 26 | 1 | 1 | Yes | No |
| 16944554 | METHOD OF PRODUCING A 2-((METH)ALLYLOXYMETHYL)ACRYLIC ACID DERIVATIVE, AND 2-((METH)ALLYLOXYMETHYL)ACRYLIC ACID ALKALI METAL SALT POWDER | July 2020 | March 2023 | Allow | 31 | 2 | 1 | Yes | No |
| 16965546 | PENTAFLUOROSULFANYL-SUBSTITUTED AMIDE DERIVATIVES, PREPARATION METHODS THEREOF AND MEDICAL USES THEREOF | July 2020 | May 2022 | Allow | 22 | 1 | 1 | No | No |
| 16937154 | FUNCTIONALIZED LONG-CHAIN HYDROCARBON MONO- AND DI-CARBOXYLIC ACIDS AND THEIR USE FOR THE PREVENTION OR TREATMENT OF DISEASE | July 2020 | June 2021 | Allow | 11 | 3 | 1 | No | No |
| 16933212 | PROCESS FOR PREPARING AZELAIC ACID | July 2020 | August 2022 | Allow | 25 | 1 | 1 | Yes | No |
| 16963101 | C5A RECEPTOR MODULATORS | July 2020 | April 2023 | Allow | 33 | 2 | 1 | Yes | No |
| 16930578 | DIESTER COMPOUND HAVING A DIMETHYLCYCLOBUTANE RING, A PROCESS FOR PREPARING THE SAME, AND A PROCESS FOR PREPARING DIMETHYLCYCLOBUTANE COMPOUND DERIVED FROM THE DIESTER COMPOUND | July 2020 | February 2022 | Allow | 19 | 1 | 1 | Yes | No |
| 16962436 | METHOD FOR SYNTHESIZING BORONATE ESTER COMPOUND, SODIUM SALT OF BORONATE ESTER COMPOUND, AND METHOD FOR SYNTHESIZING THE SAME | July 2020 | December 2022 | Abandon | 30 | 1 | 1 | No | No |
| 16927840 | MOTUPORAMINE DERIVATIVES AS ANTIMICROBIAL AGENTS AND ANTIBIOTIC ENHANCERS AGAINST RESISTANT GRAM-NEGATIVE BACTERIA | July 2020 | June 2023 | Allow | 36 | 2 | 1 | Yes | No |
| 16910116 | SUBSTRATE TREATING LIQUID | June 2020 | May 2024 | Abandon | 47 | 2 | 1 | No | No |
| 16957550 | METHOD FOR PRODUCING SEMICARBAZIDE COMPOUND | June 2020 | July 2021 | Allow | 13 | 2 | 0 | Yes | No |
| 16955618 | METHODS OF MAKING POLYFUNCTIONAL POLYFLUORINATED COMPOUNDS | June 2020 | December 2022 | Abandon | 29 | 1 | 1 | No | No |
| 16879676 | NOVEL USES | May 2020 | May 2022 | Allow | 24 | 2 | 0 | No | No |
| 16764476 | METHOD FOR PREPARING AMINES FROM CARBONYL COMPOUNDS BY TRANSAMINASE REACTION UNDER SALT PRECIPITATION | May 2020 | February 2024 | Allow | 45 | 2 | 1 | Yes | No |
| 16872466 | METABOLICALLY STABLE VANILLIN DERIVATIVES FOR THE TREATMENT OF HYPOXIA | May 2020 | June 2021 | Allow | 13 | 1 | 1 | No | No |
| 16632592 | GINGEROL DERIVATIVE HAVING INHIBITORY ACTIVITY AGAINST BIOFILM FORMATION AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS EFFECTIVE INGREDIENT FOR PREVENTING OR TREATING BIOFILM-CAUSED INFECTION SYMPTOM | April 2020 | February 2024 | Allow | 49 | 3 | 1 | No | No |
| 16858433 | ALPHA-AMINOAMIDE DERIVATIVE COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | April 2020 | March 2021 | Allow | 11 | 1 | 1 | No | No |
| 16852622 | METHOD FOR PRODUCING PROSTAGLANDIN DERIVATIVE | April 2020 | March 2022 | Allow | 23 | 0 | 1 | No | No |
| 16842695 | PHARMACEUTICAL FORMULATIONS | April 2020 | August 2024 | Abandon | 53 | 5 | 0 | No | Yes |
| 16830037 | METHOD OF SYNTHESIZING (1R,2R)-NITROALCOHOL COMPOUND | March 2020 | January 2023 | Allow | 34 | 2 | 1 | No | No |
| 16828145 | Preservative-free Treprostinil Devices | March 2020 | December 2021 | Allow | 21 | 0 | 0 | Yes | No |
| 16827599 | IMPROVED 1,1-DISUBSTITUTED ETHYLENE PROCESS | March 2020 | March 2021 | Abandon | 12 | 1 | 1 | No | No |
| 16826045 | HYDROXYTYROSOL URSOLIC ACID ESTER WITH ANTIOXIDANT ACTIVITY AND METHODS OF PREPARING THE SAME | March 2020 | March 2021 | Allow | 12 | 1 | 0 | No | No |
| 16823150 | BIOAVAILABLE POLYAMINES | March 2020 | March 2022 | Allow | 24 | 1 | 1 | No | No |
| 16646506 | PREPARATION METHOD FOR HIGH PURITY RACEMIC ADRENALINE | March 2020 | July 2020 | Allow | 4 | 0 | 0 | Yes | No |
| 16645444 | METHOD FOR PRODUCING LACTIC ACID | March 2020 | January 2023 | Abandon | 35 | 0 | 1 | No | No |
| 16644867 | NOVEL THERAPEUTICS FOR CENTRAL NERVOUS SYSTEM DISORDERS | March 2020 | February 2022 | Allow | 24 | 1 | 1 | No | No |
| 16643962 | PROCESS AND INTERMEDIATE FOR THE MANUFACTURE OF DIFLUOROACETYL CHLORIDE | March 2020 | December 2022 | Abandon | 33 | 0 | 1 | No | No |
| 16807747 | COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING NEURODEGENERATIVE DISORDERS | March 2020 | April 2021 | Allow | 14 | 0 | 1 | Yes | No |
| 16643327 | METHOD FOR PRODUCING BENZOYL FORMIC ACID COMPOUND AND PYRIDAZINE COMPOUND | February 2020 | April 2022 | Abandon | 26 | 0 | 1 | No | No |
| 16788808 | 7-METHYL-3-METHYLENE-7-OCTENAL ACETAL COMPUND AND METHODS FOR PRODUCING ALDEHYDE COMPOUND AND ESTER COMPOUND USING THE SAME | February 2020 | April 2022 | Allow | 26 | 1 | 1 | No | No |
| 16636955 | METHOD FOR PREPARING LATANOPROSTENE BUNOD, AND INTERMEDIATE THEREFOR | February 2020 | August 2020 | Allow | 7 | 0 | 1 | No | No |
| 16635234 | PROCESS FOR THE PREPARATION OF ELAFIBRANOR AND NOVEL SYNTHESIS INTERMEDIATES | January 2020 | June 2022 | Allow | 28 | 1 | 1 | Yes | No |
| 16749519 | PROCESS FOR CONVERTING S-ENANTIOMER TO ITS RACEMIC FORM | January 2020 | November 2021 | Allow | 22 | 0 | 1 | No | No |
| 16739645 | 1,3-FATTY DIOL COMPOUNDS AND DERIVATIVES THEREOF | January 2020 | July 2021 | Allow | 18 | 1 | 0 | No | No |
| 16629742 | Method for Producing Herbicide Intermediate | January 2020 | December 2021 | Allow | 23 | 2 | 0 | Yes | No |
| 16629427 | CONVERSION OF POLYSTYRENE TO BENZOIC ACID | January 2020 | May 2022 | Abandon | 28 | 1 | 1 | No | No |
| 16734824 | METHOD FOR PREPARING A β -HYDROXYCARBOXYLIC ACID ESTER | January 2020 | April 2021 | Allow | 15 | 2 | 1 | Yes | No |
| 16627016 | Process for the Preparation of a Mixture of Chelating Agents, Mixture of Chelating Agents and Methods of Using Them | December 2019 | February 2023 | Allow | 37 | 1 | 1 | Yes | No |
| 16624318 | METHOD FOR PRODUCING 3-HYDROXY-3-METHYLBUTYRATE OR SALT THEREOF | December 2019 | August 2022 | Abandon | 32 | 2 | 1 | No | No |
| 16624183 | METHOD FOR PREPARING SUBSTITUTED 4-AMINOINDANE DERIVATIVES | December 2019 | August 2021 | Allow | 19 | 0 | 1 | Yes | No |
| 16618902 | BIODEGRADABLE DIETHANOLAMINE DERIVATIVE CHELATING AGENT AND PREPARATION PROCESS THEREOF | December 2019 | March 2021 | Abandon | 15 | 1 | 1 | No | No |
| 16618597 | SURFACTANTS FOR THE TREATMENT OF CONDITIONS THROUGH TARGETED NECROSIS | December 2019 | February 2022 | Abandon | 27 | 1 | 1 | No | No |
| 16617428 | METHODS OF MAKING OLEFINIC E- AND Z-ISOMERS | November 2019 | April 2022 | Allow | 29 | 1 | 1 | No | No |
| 16690298 | INHIBITORS OF METALLO-BETA-LACTAMASES PRODUCED BY MULTIDRUG-RESISTANT BACTERIA | November 2019 | February 2022 | Allow | 26 | 2 | 1 | Yes | No |
| 16613810 | Catalyst for Catalytic Oxidation of Furfural to Prepare Maleic Acid and Application Thereof | November 2019 | October 2021 | Allow | 23 | 1 | 1 | Yes | No |
| 16611926 | CRYSTAL FORM AND AMORPHOUS FORM OF DEZOCINE ANALOGUE HYDROCHLORIDE | November 2019 | January 2022 | Allow | 27 | 1 | 1 | Yes | No |
| 16665114 | N-(7-FLUORO-1,1,3-TRIMETHYL -1 H-INDEN-4YL) AMIDES AND A PROCESS FOR PREPARING SAME | October 2019 | August 2021 | Allow | 22 | 1 | 0 | No | No |
| 16608599 | ELECTROLUMINESCENT MATERIAL, METHOD FOR MANUFACTURING SAME, AND LIGHT EMITTING DEVICE | October 2019 | May 2023 | Abandon | 42 | 1 | 1 | No | No |
| 16608592 | Novel Compositions For Preventing And/Or Treating Degenerative Disorders Of The Central Nervous System And/Or Lysosomal Storage Disorders | October 2019 | February 2022 | Allow | 27 | 2 | 1 | Yes | No |
| 16662517 | POLYMORPHIC COMPOUNDS AND USES THEREOF | October 2019 | January 2022 | Allow | 27 | 1 | 1 | Yes | No |
| 16607772 | LIPOPEPTIDE COMPOUNDS FOR THE TREATMENT OF PAIN DISORDERS | October 2019 | April 2022 | Allow | 30 | 1 | 1 | Yes | No |
| 16491105 | LEONURINE CRYSTAL AND USE THEREOF IN PREPARATION OF INSULIN SENSITIZER, HYPOGLYCEMIC DRUG AND LIPID-LOWERING DRUG | October 2019 | May 2022 | Allow | 32 | 1 | 1 | Yes | No |
| 16605645 | OPTICALLY-ACTIVE 2-AMINO-PHOSPHONOALKANE ACID, OPTICALLY-ACTIVE 2-AMINOPHOSPHONOALKANE ACID SALT, AND HYDRATES OF THESE | October 2019 | September 2021 | Allow | 23 | 1 | 1 | Yes | No |
| 16598694 | CRYSTALLINE SOLVATE FORMS OF A PHARMACEUTICAL | October 2019 | March 2021 | Allow | 17 | 1 | 0 | No | No |
| 16604298 | LIPID DERIVATIVE FOR NUCLEIC ACID INTRODUCTION | October 2019 | March 2021 | Allow | 17 | 0 | 1 | Yes | No |
| 16603874 | Novel Alpha-Hydroxy Carboxylic Acid and Derivatives and Other GRAS-Based Amide and Imide Prodrugs of Amphetamine Compounds and Uses Thereof | October 2019 | April 2022 | Abandon | 30 | 2 | 1 | No | No |
| 16603880 | Novel Alpha-Hydroxy Carboxylic Acid And Derivatives And Other GRAS- Based Prodrugs Of Gamma-Hydroxybutyrate (GHB) And Uses Thereof | October 2019 | September 2023 | Abandon | 47 | 4 | 1 | No | No |
| 16499626 | CHEMICAL PROCESS OF PREPARING DEHYDROHEDIONE | September 2019 | October 2021 | Allow | 24 | 3 | 0 | Yes | No |
| 16498313 | PROCESS AND SYSTEMS FOR OBTAINING 1,3-BUTANEDIOL FROM FERMENTATION BROTHS | September 2019 | May 2024 | Abandon | 55 | 2 | 1 | No | Yes |
| 16579545 | PSYCHOTROPIC AGENTS AND USES THEREOF | September 2019 | February 2022 | Allow | 29 | 2 | 0 | Yes | No |
| 16496598 | ALIPHATIC AMINE AND ITS PREPARATION METHOD AND USE | September 2019 | November 2021 | Abandon | 26 | 0 | 1 | No | No |
| 16495907 | Cu- and Ni-Catalyzed Decarboxylative Borylation Reactions | September 2019 | July 2021 | Allow | 22 | 1 | 1 | Yes | No |
| 16574335 | NICKEL DIATOMACEOUS EARTH CATALYST AND METHOD FOR PRODUCING THE SAME | September 2019 | August 2020 | Allow | 11 | 1 | 0 | Yes | No |
| 16495360 | Catalytic Process For Synthesizing N,N-Dimethyl Glucamine From N Methyl Glucamine | September 2019 | September 2021 | Abandon | 24 | 1 | 0 | No | No |
| 16492256 | NOVEL COMPOSITION OF 7,9-DODECADIENYL-1-ACETATE ISOMERS AND PROCESS FOR PRODUCTION THEREOF | September 2019 | January 2023 | Allow | 40 | 2 | 1 | Yes | No |
| 16490989 | METHODS FOR FORMING 1,3,5,7-TETRAALKYL-6-(2,4-DIMETHOXYPHENYL)-2,4,8-TRIOXA-6-PHOSPHAADAMANTANE | September 2019 | May 2021 | Allow | 20 | 1 | 1 | No | No |
| 16560146 | BRANCHED ACETAL COALESCING AIDS | September 2019 | March 2022 | Abandon | 30 | 1 | 1 | No | No |
| 16490598 | METHOD FOR SYNTHESIZING KETOXIME | September 2019 | January 2020 | Allow | 5 | 1 | 0 | Yes | No |
| 16558125 | PdIn Alloy Catalyst, Method for Manufacturing PdIn Alloy Catalyst and Application Thereof | September 2019 | June 2020 | Allow | 9 | 1 | 1 | Yes | No |
| 16556466 | ORGANIC SEMICONDUCTING MATERIAL AND ITS SYNTHESIS AND ORGANIC SEMICONDUCTING COMPONENT WITH THE MATERIAL | August 2019 | December 2021 | Allow | 27 | 2 | 1 | Yes | No |
| 16557967 | AMINE-CONTAINING TRANSFECTION REAGENTS AND METHODS FOR MAKING AND USING SAME | August 2019 | May 2022 | Allow | 32 | 2 | 1 | Yes | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner MURESAN, ANA Z.
With a 100.0% reversal rate, the PTAB has reversed the examiner's rejections more often than affirming them. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 22.2% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is below the USPTO average, suggesting that filing an appeal has limited effectiveness in prompting favorable reconsideration.
✓ Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner MURESAN, ANA Z works in Art Unit 1622 and has examined 326 patent applications in our dataset. With an allowance rate of 75.2%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 25 months.
Examiner MURESAN, ANA Z's allowance rate of 75.2% places them in the 42% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.
On average, applications examined by MURESAN, ANA Z receive 1.51 office actions before reaching final disposition. This places the examiner in the 24% percentile for office actions issued. This examiner issues significantly fewer office actions than most examiners.
The median time to disposition (half-life) for applications examined by MURESAN, ANA Z is 25 months. This places the examiner in the 77% percentile for prosecution speed. Applications move through prosecution relatively quickly with this examiner.
Conducting an examiner interview provides a +41.4% benefit to allowance rate for applications examined by MURESAN, ANA Z. This interview benefit is in the 87% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 31.3% of applications are subsequently allowed. This success rate is in the 66% percentile among all examiners. Strategic Insight: RCEs show above-average effectiveness with this examiner. Consider whether your amendments or new arguments are strong enough to warrant an RCE versus filing a continuation.
This examiner enters after-final amendments leading to allowance in 40.0% of cases where such amendments are filed. This entry rate is in the 62% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.
When applicants request a pre-appeal conference (PAC) with this examiner, 200.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 93% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.
This examiner withdraws rejections or reopens prosecution in 75.0% of appeals filed. This is in the 63% percentile among all examiners. Of these withdrawals, 33.3% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.
When applicants file petitions regarding this examiner's actions, 70.2% are granted (fully or in part). This grant rate is in the 76% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 1% percentile). This examiner rarely makes examiner's amendments compared to other examiners. You should expect to make all necessary claim amendments yourself through formal amendment practice.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 1% percentile). This examiner rarely issues Quayle actions compared to other examiners. Allowances typically come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.